logo
Plus   Neg
Share
Email

Hikma Pharma Gets Rights To Commercialise 11 Of Chiesi's Products In Egypt

Hikma Pharmaceuticals PLC (HIK.L) has reached an exclusive licensing and distribution agreement with Chiesi Farmaceutici, which provides Hikma with exclusive rights to commercialise 11 of Chiesi's products in Egypt. These specialty products are primarily in respiratory and neonatal therapeutic areas.

Hikma Pharma said the new agreement, which builds on the company's existing partnership with Chiesi in Morocco, adds a range of products to the Egyptian portfolio, including Foster, Foster Nexthaler, Trimbow and Curosurf.

Chiesi Farmaceutici is a research-focused international pharmaceutical Group, headquartered in Italy.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The chief executive officer of Google's parent company Alphabet called for artificial intelligence or AI to be regulated, noting that there are real concerns about the potential negative consequences of the technology. According to Alphabet CEO Sundar Pichai, there are real concerns about the negative consequences of AI, from deepfakes to nefarious uses of facial recognition. Walt Disney Co.'s (DIS) streaming service Disney+ will be launched on March 24 in the UK and other markets in the Western Europe, one week earlier than originally planned on March 31. Pricing also been confirmed at 5.99 pounds/6.99 euros per month or 59.99 pounds/69.99 euros for an annual subscription.... Facebook plans to add 1,000 new jobs in the UK this year, with more than half of this focused on technology. The new jobs come ahead of Facebook's planned opening of its new office premises in King's Cross, London next year. It will take the social media giant's total employee count in the UK to more than 4,000 by the end of this year.
Follow RTT
>